CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives
Despite increasing efforts and support for anti-malarial drug R&D, globally anti-malarial drug discovery and development remains largely uncoordinated and fragmented. The current window of opportunity for large scale funding of R&D into malaria is likely to narrow in the coming decade due to...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
13 July 2010
|
| In: |
Malaria journal
Year: 2010, Jahrgang: 9, Pages: 1-8 |
| ISSN: | 1475-2875 |
| DOI: | 10.1186/1475-2875-9-202 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1475-2875-9-202 |
| Verfasserangaben: | Ian C Boulton, Solomon Nwaka, Ian Bathurst, Michael Lanzer, Donatella Taramelli, Henri Vial, Christian Doerig, Kelly Chibale and Steve A Ward |
| Zusammenfassung: | Despite increasing efforts and support for anti-malarial drug R&D, globally anti-malarial drug discovery and development remains largely uncoordinated and fragmented. The current window of opportunity for large scale funding of R&D into malaria is likely to narrow in the coming decade due to a contraction in available resources caused by the current economic difficulties and new priorities (e.g. climate change). It is, therefore, essential that stakeholders are given well-articulated action plans and priorities to guide judgments on where resources can be best targeted. |
|---|---|
| Beschreibung: | Gesehen am 15.02.2023 |
| Beschreibung: | Online Resource |
| ISSN: | 1475-2875 |
| DOI: | 10.1186/1475-2875-9-202 |